KEGG Orthology (KO) - Homo sapiens (human)

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level 

     KO
 09100 Metabolism
 
 09120 Genetic Information Processing
 
 09130 Environmental Information Processing
 
 09140 Cellular Processes
 
 09150 Organismal Systems
 
   09151 Immune system
     04640 Hematopoietic cell lineage [PATH:hsa04640]
     04610 Complement and coagulation cascades [PATH:hsa04610]
     04611 Platelet activation [PATH:hsa04611]
     04613 Neutrophil extracellular trap formation [PATH:hsa04613]
     04620 Toll-like receptor signaling pathway [PATH:hsa04620]
     04624 Toll and Imd signaling pathway
     04621 NOD-like receptor signaling pathway [PATH:hsa04621]
       10392 NOD1; nucleotide binding oligomerization domain containing 1
       8767 RIPK2; receptor interacting serine/threonine kinase 2
       8517 IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
       1147 CHUK; component of inhibitor of nuclear factor kappa B kinase complex
       3551 IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta
       4793 NFKBIB; NFKB inhibitor beta
       4792 NFKBIA; NFKB inhibitor alpha
       4790 NFKB1; nuclear factor kappa B subunit 1
       5970 RELA; RELA proto-oncogene, NF-kB subunit
       3553 IL1B; interleukin 1 beta
       3606 IL18; interleukin 18
       3569 IL6; interleukin 6
       7124 TNF; tumor necrosis factor
       3576 CXCL8; C-X-C motif chemokine ligand 8
       2919 CXCL1; C-X-C motif chemokine ligand 1
       2920 CXCL2; C-X-C motif chemokine ligand 2
       2921 CXCL3; C-X-C motif chemokine ligand 3
       6347 CCL2; C-C motif chemokine ligand 2
       6352 CCL5; C-C motif chemokine ligand 5
       820 CAMP; cathelicidin antimicrobial peptide
       1667 DEFA1; defensin alpha 1
       1668 DEFA3; defensin alpha 3
       1669 DEFA4; defensin alpha 4
       1670 DEFA5; defensin alpha 5
       1671 DEFA6; defensin alpha 6
       728358 DEFA1B; defensin alpha 1B
       1673 DEFB4A; defensin beta 4A
       100289462 DEFB4B; defensin beta 4B
       414325 DEFB103A; defensin beta 103A
       55894 DEFB103B; defensin beta 103B
       64127 NOD2; nucleotide binding oligomerization domain containing 2
       6885 MAP3K7; mitogen-activated protein kinase kinase kinase 7
       10454 TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1
       23118 TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2
       257397 TAB3; TGF-beta activated kinase 1 (MAP3K7) binding protein 3
       5594 MAPK1; mitogen-activated protein kinase 1
       5595 MAPK3; mitogen-activated protein kinase 3
       5599 MAPK8; mitogen-activated protein kinase 8
       5602 MAPK10; mitogen-activated protein kinase 10
       5601 MAPK9; mitogen-activated protein kinase 9
       5600 MAPK11; mitogen-activated protein kinase 11
       6300 MAPK12; mitogen-activated protein kinase 12
       5603 MAPK13; mitogen-activated protein kinase 13
       1432 MAPK14; mitogen-activated protein kinase 14
       3725 JUN; Jun proto-oncogene, AP-1 transcription factor subunit
       55054 ATG16L1; autophagy related 16 like 1
       9474 ATG5; autophagy related 5
       9140 ATG12; autophagy related 12
       11337 GABARAP; GABA type A receptor-associated protein
       23710 GABARAPL1; GABA type A receptor associated protein like 1
       11345 GABARAPL2; GABA type A receptor associated protein like 2
       440738 MAP1LC3C; microtubule associated protein 1 light chain 3 gamma
       81631 MAP1LC3B; microtubule associated protein 1 light chain 3 beta
       84557 MAP1LC3A; microtubule associated protein 1 light chain 3 alpha
       643246 MAP1LC3B2; microtubule associated protein 1 light chain 3 beta 2
       10910 SUGT1; SGT1 homolog, MIS12 kinetochore complex assembly cochaperone
       81858 SHARPIN; SHANK associated RH domain interactor
       10616 RBCK1; RANBP2-type and C3HC4-type zinc finger containing 1
       55072 RNF31; ring finger protein 31
       331 XIAP; X-linked inhibitor of apoptosis
       84674 CARD6; caspase recruitment domain family member 6
       7205 TRIP6; thyroid hormone receptor interactor 6
       55914 ERBIN; erbb2 interacting protein
       329 BIRC2; baculoviral IAP repeat containing 2
       330 BIRC3; baculoviral IAP repeat containing 3
       7186 TRAF2; TNF receptor associated factor 2
       7188 TRAF5; TNF receptor associated factor 5
       7189 TRAF6; TNF receptor associated factor 6
       64170 CARD9; caspase recruitment domain family member 9
       7128 TNFAIP3; TNF alpha induced protein 3
       57506 MAVS; mitochondrial antiviral signaling protein
       7187 TRAF3; TNF receptor associated factor 3
       29110 TBK1; TANK binding kinase 1
       9641 IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon
       10010 TANK; TRAF family member associated NFKB activator
       3661 IRF3; interferon regulatory factor 3
       3665 IRF7; interferon regulatory factor 7
       3439 IFNA1; interferon alpha 1
       3440 IFNA2; interferon alpha 2
       3441 IFNA4; interferon alpha 4
       3442 IFNA5; interferon alpha 5
       3443 IFNA6; interferon alpha 6
       3444 IFNA7; interferon alpha 7
       3445 IFNA8; interferon alpha 8
       3446 IFNA10; interferon alpha 10
       3447 IFNA13; interferon alpha 13
       3448 IFNA14; interferon alpha 14
       3449 IFNA16; interferon alpha 16
       3451 IFNA17; interferon alpha 17
       3452 IFNA21; interferon alpha 21
       3456 IFNB1; interferon beta 1
       79671 NLRX1; NLR family member X1
       118429 ANTXR2; ANTXR cell adhesion molecule 2
       84168 ANTXR1; ANTXR cell adhesion molecule 1
       22861 NLRP1; NLR family pyrin domain containing 1
       29108 PYCARD; PYD and CARD domain containing
       834 CASP1; caspase 1
       596 BCL2; BCL2 apoptosis regulator
       598 BCL2L1; BCL2 like 1
       1508 CTSB; cathepsin B
       114548 NLRP3; NLR family pyrin domain containing 3
       24145 PANX1; pannexin 1
       5027 P2RX7; purinergic receptor P2X 7
       7226 TRPM2; transient receptor potential cation channel subfamily M member 2
       54822 TRPM7; transient receptor potential cation channel subfamily M member 7
       51393 TRPV2; transient receptor potential cation channel subfamily V member 2
       846 CASR; calcium sensing receptor
       222545 GPRC6A; G protein-coupled receptor class C group 6 member A
       23236 PLCB1; phospholipase C beta 1
       5330 PLCB2; phospholipase C beta 2
       5331 PLCB3; phospholipase C beta 3
       5332 PLCB4; phospholipase C beta 4
       3708 ITPR1; inositol 1,4,5-trisphosphate receptor type 1
       3709 ITPR2; inositol 1,4,5-trisphosphate receptor type 2
       3710 ITPR3; inositol 1,4,5-trisphosphate receptor type 3
       7416 VDAC1; voltage dependent anion channel 1
       7417 VDAC2; voltage dependent anion channel 2
       7419 VDAC3; voltage dependent anion channel 3
       90550 MCU; mitochondrial calcium uniporter
       4938 OAS1; 2'-5'-oligoadenylate synthetase 1
       4939 OAS2; 2'-5'-oligoadenylate synthetase 2
       4940 OAS3; 2'-5'-oligoadenylate synthetase 3
       6041 RNASEL; ribonuclease L
       56919 DHX33; DEAH-box helicase 33
       55669 MFN1; mitofusin 1
       9927 MFN2; mitofusin 2
       8737 RIPK1; receptor interacting serine/threonine kinase 1
       11035 RIPK3; receptor interacting serine/threonine kinase 3
       10059 DNM1L; dynamin 1 like
       10135 NAMPT; nicotinamide phosphoribosyltransferase
       1536 CYBB; cytochrome b-245 beta chain
       1535 CYBA; cytochrome b-245 alpha chain
       10628 TXNIP; thioredoxin interacting protein
       7295 TXN; thioredoxin
       25828 TXN2; thioredoxin 2
       140609 NEK7; NIMA related kinase 7
       79184 BRCC3; BRCA1/BRCA2-containing complex subunit 3
       3320 HSP90AA1; heat shock protein 90 alpha family class A member 1
       3326 HSP90AB1; heat shock protein 90 alpha family class B member 1
       22900 CARD8; caspase recruitment domain family member 8
       63940 GPSM3; G protein signaling modulator 3
       345611 IRGM; immunity related GTPase M
       260434 PYDC1; pyrin domain containing 1
       152138 PYDC2; pyrin domain containing 2
       4210 MEFV; MEFV innate immunity regulator, pyrin
       9051 PSTPIP1; proline-serine-threonine phosphatase interacting protein 1
       841 CASP8; caspase 8
       8772 FADD; Fas associated via death domain
       100506742 CASP12; caspase 12 (gene/pseudogene)
       59082 CARD18; caspase recruitment domain family member 18
       114769 CARD16; caspase recruitment domain family member 16
       171389 NLRP6; NLR family pyrin domain containing 6
       199713 NLRP7; NLR family pyrin domain containing 7
       91662 NLRP12; NLR family pyrin domain containing 12
       4671 NAIP; NLR family apoptosis inhibitory protein
       58484 NLRC4; NLR family CARD domain containing 4
       5580 PRKCD; protein kinase C delta
       2634 GBP2; guanylate binding protein 2
       115362 GBP5; guanylate binding protein 5
       9447 AIM2; absent in melanoma 2
       3428 IFI16; interferon gamma inducible protein 16
       7158 TP53BP1; tumor protein p53 binding protein 1
       107181291 PYDC5; pyrin domain containing 5
       387 RHOA; ras homolog family member A
       5585 PKN1; protein kinase N1
       5586 PKN2; protein kinase N2
       7531 YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon
       2633 GBP1; guanylate binding protein 1
       2635 GBP3; guanylate binding protein 3
       115361 GBP4; guanylate binding protein 4
       388646 GBP7; guanylate binding protein 7
       838 CASP5; caspase 5
       837 CASP4; caspase 4
       79792 GSDMD; gasdermin D
       3454 IFNAR1; interferon alpha and beta receptor subunit 1
       3455 IFNAR2; interferon alpha and beta receptor subunit 2
       3716 JAK1; Janus kinase 1
       7297 TYK2; tyrosine kinase 2
       6772 STAT1; signal transducer and activator of transcription 1
       6773 STAT2; signal transducer and activator of transcription 2
       10379 IRF9; interferon regulatory factor 9
       7099 TLR4; toll like receptor 4
       148022 TICAM1; TIR domain containing adaptor molecule 1
       4615 MYD88; MYD88 innate immune signal transduction adaptor
       51135 IRAK4; interleukin 1 receptor associated kinase 4
       340061 STING1; stimulator of interferon response cGAMP interactor 1
K08727 NOD1; nucleotide-binding oligomerization domain-containing protein 1
K08846 RIPK2; receptor-interacting serine/threonine-protein kinase 2 [EC:2.7.11.1]
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K02581 NFKBIB; NF-kappa-B inhibitor beta
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K04519 IL1B; interleukin 1 beta
K05482 IL18; interleukin 18
K05405 IL6; interleukin 6
K03156 TNF; tumor necrosis factor superfamily, member 2
K10030 IL8; interleukin 8
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K14624 CCL2; C-C motif chemokine 2
K12499 CCL5; C-C motif chemokine 5
K13916 CAMP; cathelicidin antimicrobial peptide
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K21100 DEFB4; beta-defensin 4
K21100 DEFB4; beta-defensin 4
K23126 DEFB103; beta-defensin 103
K23126 DEFB103; beta-defensin 103
K10165 NOD2; nucleotide-binding oligomerization domain-containing protein 2
K04427 MAP3K7; mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
K04403 MAP3K7IP1; TAK1-binding protein 1
K04404 MAP3K7IP2; TAK1-binding protein 2
K12793 MAP3K7IP3; TAK1-binding protein 3
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04448 JUN; transcription factor AP-1
K17890 ATG16L1; autophagy-related protein 16-1
K08339 ATG5; autophagy-related protein 5
K08336 ATG12; ubiquitin-like protein ATG12
K08341 GABARAP; GABA(A) receptor-associated protein
K08341 GABARAP; GABA(A) receptor-associated protein
K08341 GABARAP; GABA(A) receptor-associated protein
K10435 MAP1LC; microtubule-associated protein 1 light chain
K10435 MAP1LC; microtubule-associated protein 1 light chain
K10435 MAP1LC; microtubule-associated protein 1 light chain
K10435 MAP1LC; microtubule-associated protein 1 light chain
K12795 SUGT1; suppressor of G2 allele of SKP1
K20894 SHARPIN; shank-associated RH domain-interacting protein
K10630 RBCK1; RanBP-type and C3HC4-type zinc finger-containing protein 1 [EC:2.3.2.31]
K11974 RNF31; E3 ubiquitin-protein ligase RNF31 [EC:2.3.2.31]
K04725 XIAP; E3 ubiquitin-protein ligase XIAP [EC:2.3.2.27]
K12797 CARD6; caspase recruitment domain-containing protein 6
K12792 TRIP6; thyroid receptor-interacting protein 6
K12796 ERBIN; erbb2-interacting protein
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K03173 TRAF2; TNF receptor-associated factor 2 [EC:2.3.2.27]
K09849 TRAF5; TNF receptor-associated factor 5
K03175 TRAF6; TNF receptor-associated factor 6 [EC:2.3.2.27]
K12794 CARD9; caspase recruitment domain-containing protein 9
K11859 TNFAIP3; tumor necrosis factor, alpha-induced protein 3 [EC:3.4.19.12]
K12648 MAVS; mitochondrial antiviral-signaling protein
K03174 TRAF3; TNF receptor-associated factor 3
K05410 TBK1; TANK-binding kinase 1 [EC:2.7.11.10]
K07211 IKBKE; inhibitor of nuclear factor kappa-B kinase subunit epsilon [EC:2.7.11.10]
K12650 TANK; TRAF family member-associated NF-kappa-B activator
K05411 IRF3; interferon regulatory factor 3
K09447 IRF7; interferon regulatory factor 7
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05415 IFNB; interferon beta
K12653 NLRX1; NLR family member X1
K20909 ANTXR; anthrax toxin receptor
K20909 ANTXR; anthrax toxin receptor
K12798 NLRP1; NACHT, LRR and PYD domains-containing protein 1
K12799 PYCARD; apoptosis-associated speck-like protein containing a CARD
K01370 CASP1; caspase 1 [EC:3.4.22.36]
K02161 BCL2; apoptosis regulator Bcl-2
K04570 BCL2L1; Bcl-2-like 1 (apoptosis regulator Bcl-X)
K01363 CTSB; cathepsin B [EC:3.4.22.1]
K12800 NLRP3; NACHT, LRR and PYD domains-containing protein 3
K03443 PANX1; pannexin 1
K05220 P2RX7; P2X purinoceptor 7
K04977 TRPM2; transient receptor potential cation channel subfamily M member 2 [EC:3.6.1.13]
K04982 TRPM7; transient receptor potential cation channel subfamily M member 7 [EC:2.7.11.1]
K04971 TRPV2; transient receptor potential cation channel subfamily V member 2
K04612 CASR; calcium-sensing receptor
K04622 GPRC6A; G protein-coupled receptor family C group 6 member A
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K04958 ITPR1; inositol 1,4,5-triphosphate receptor type 1
K04959 ITPR2; inositol 1,4,5-triphosphate receptor type 2
K04960 ITPR3; inositol 1,4,5-triphosphate receptor type 3
K05862 VDAC1; voltage-dependent anion channel protein 1
K15040 VDAC2; voltage-dependent anion channel protein 2
K15041 VDAC3; voltage-dependent anion channel protein 3
K20858 MCU; calcium uniporter protein, mitochondrial
K14216 OAS; 2'-5'-oligoadenylate synthetase [EC:2.7.7.84]
K14216 OAS; 2'-5'-oligoadenylate synthetase [EC:2.7.7.84]
K14216 OAS; 2'-5'-oligoadenylate synthetase [EC:2.7.7.84]
K01165 RNASEL; ribonuclease L
K17820 DHX33; ATP-dependent RNA helicase DHX33 [EC:5.6.2.6]
K21356 MFN1; mitofusin 1 [EC:3.6.5.-]
K06030 MFN2; mitofusin 2 [EC:3.6.5.-]
K02861 RIPK1; receptor-interacting serine/threonine-protein kinase 1 [EC:2.7.11.1]
K08847 RIPK3; receptor-interacting serine/threonine-protein kinase 3 [EC:2.7.11.1]
K17065 DNM1L; dynamin 1-like protein [EC:3.6.5.5]
K03462 NAMPT; nicotinamide phosphoribosyltransferase [EC:2.4.2.12]
K21421 NOX2; NADPH oxidase 2 [EC:1.-.-.-]
K08009 CYBA; cytochrome b-245, alpha polypeptide
K20910 TXNIP; thioredoxin-interacting protein
K03671 TXN; thioredoxin
K03671 TXN; thioredoxin
K20876 NEK7; serine/threonine-protein kinase Nek7 [EC:2.7.11.34]
K11864 BRCC3; BRCA1/BRCA2-containing complex subunit 3 [EC:3.4.19.-]
K04079 HSP90A; molecular chaperone HtpG
K04079 HSP90A; molecular chaperone HtpG
K12801 CARD8; caspase recruitment domain-containing protein 8
K15838 GPSM3; G-protein signaling modulator 3
K14139 IRGM; immunity-related GTPase family M protein [EC:3.6.5.-]
K12802 PYDC1; pyrin domain-containing protein 1
K20911 PYDC2; pyrin domain-containing protein 2
K12803 MEFV; pyrin
K12804 PSTPIP1; proline-serine-threonine phosphatase interacting protein 1
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K02373 FADD; FAS-associated death domain protein
K04741 CASP12; caspase 12 [EC:3.4.22.-]
K12806 CARD16_17_18; caspase recruitment domain-containing protein 16/17/18
K12806 CARD16_17_18; caspase recruitment domain-containing protein 16/17/18
K20863 NLRP6; NACHT, LRR and PYD domains-containing protein 6
K20864 NLRP7; NACHT, LRR and PYD domains-containing protein 7
K20865 NLRP12; NACHT, LRR and PYD domains-containing protein 12
K12807 NAIP; baculoviral IAP repeat-containing protein 1
K12805 NLRC4; NLR family CARD domain-containing protein 4
K06068 PRKCD; novel protein kinase C delta type [EC:2.7.11.13]
K20897 GBP2; guanylate-binding protein 2
K20898 GBP5; guanylate-binding protein 5
K12966 AIM2; absent in melanoma 2
K20914 IFI16; gamma-interferon-inducible protein 16
K20915 TP53BP1; tumor suppressor p53-binding protein 1
K20916 POP3; pyrin domain-only protein 3
K04513 RHOA; Ras homolog gene family, member A
K06071 PKN1; serine/threonine-protein kinase N1 [EC:2.7.11.13]
K23691 PKN2; serine/threonine-protein kinase N2 [EC:2.7.11.13]
K06630 YWHAE; 14-3-3 protein epsilon
K20899 GBP1_3_4_7; guanylate-binding protein 1/3/4/7
K20899 GBP1_3_4_7; guanylate-binding protein 1/3/4/7
K20899 GBP1_3_4_7; guanylate-binding protein 1/3/4/7
K20899 GBP1_3_4_7; guanylate-binding protein 1/3/4/7
K04395 CASP5; caspase 5 [EC:3.4.22.58]
K04394 CASP4; caspase 4 [EC:3.4.22.57 3.4.22.64]
K20917 GSDMD; gasdermin-D
K05130 IFNAR1; interferon receptor 1
K05131 IFNAR2; interferon receptor 2
K11217 JAK1; Janus kinase 1 [EC:2.7.10.2]
K11219 TYK2; non-receptor tyrosine-protein kinase TYK2 [EC:2.7.10.2]
K11220 STAT1; signal transducer and activator of transcription 1
K11221 STAT2; signal transducer and activator of transcription 2
K04693 IRF9; interferon regulatory factor 9
K10160 TLR4; toll-like receptor 4
K05842 TRIF; toll-like receptor adapter molecule 1
K04729 MYD88; myeloid differentiation primary response protein MyD88
K04733 IRAK4; interleukin-1 receptor-associated kinase 4 [EC:2.7.11.1]
K12654 STING1; stimulator of interferon genes protein
     04622 RIG-I-like receptor signaling pathway [PATH:hsa04622]
     04623 Cytosolic DNA-sensing pathway [PATH:hsa04623]
     04625 C-type lectin receptor signaling pathway [PATH:hsa04625]
     04650 Natural killer cell mediated cytotoxicity [PATH:hsa04650]
     04612 Antigen processing and presentation [PATH:hsa04612]
     04660 T cell receptor signaling pathway [PATH:hsa04660]
     04658 Th1 and Th2 cell differentiation [PATH:hsa04658]
     04659 Th17 cell differentiation [PATH:hsa04659]
     04657 IL-17 signaling pathway [PATH:hsa04657]
     04662 B cell receptor signaling pathway [PATH:hsa04662]
     04664 Fc epsilon RI signaling pathway [PATH:hsa04664]
     04666 Fc gamma R-mediated phagocytosis [PATH:hsa04666]
     04670 Leukocyte transendothelial migration [PATH:hsa04670]
     04672 Intestinal immune network for IgA production [PATH:hsa04672]
     04062 Chemokine signaling pathway [PATH:hsa04062]
 
   09152 Endocrine system
 
   09153 Circulatory system
 
   09154 Digestive system
 
   09155 Excretory system
 
   09156 Nervous system
 
   09157 Sensory system
 
   09158 Development and regeneration
 
   09149 Aging
 
   09159 Environmental adaptation
 
 09160 Human Diseases
 
   09161 Cancer: overview
     05200 Pathways in cancer [PATH:hsa05200]
     05202 Transcriptional misregulation in cancer [PATH:hsa05202]
       861 RUNX1; RUNX family transcription factor 1
       1436 CSF1R; colony stimulating factor 1 receptor
       4353 MPO; myeloperoxidase
       1437 CSF2; colony stimulating factor 2
       3562 IL3; interleukin 3
       862 RUNX1T1; RUNX1 partner transcriptional co-repressor 1
       3065 HDAC1; histone deacetylase 1
       3066 HDAC2; histone deacetylase 2
       25942 SIN3A; SIN3 transcription regulator family member A
       9611 NCOR1; nuclear receptor corepressor 1
       1050 CEBPA; CCAAT enhancer binding protein alpha
       8864 PER2; period circadian regulator 2
       6688 SPI1; Spi-1 proto-oncogene
       929 CD14; CD14 molecule
       3684 ITGAM; integrin subunit alpha M
       2209 FCGR1A; Fc gamma receptor Ia
       3728 JUP; junction plakoglobin
       5371 PML; PML nuclear body scaffold
       5914 RARA; retinoic acid receptor alpha
       890 CCNA2; cyclin A2
       8900 CCNA1; cyclin A1
       1053 CEBPE; CCAAT enhancer binding protein epsilon
       597 BCL2A1; BCL2 related protein A1
       7704 ZBTB16; zinc finger and BTB domain containing 16
       4609 MYC; MYC proto-oncogene, bHLH transcription factor
       1848 DUSP6; dual specificity phosphatase 6
       6929 TCF3; transcription factor 3
       5087 PBX1; PBX homeobox 1
       51384 WNT16; Wnt family member 16
       2120 ETV6; ETS variant transcription factor 6
       51513 ETV7; ETS variant transcription factor 7
       1667 DEFA1; defensin alpha 1
       1668 DEFA3; defensin alpha 3
       1669 DEFA4; defensin alpha 4
       1670 DEFA5; defensin alpha 5
       1671 DEFA6; defensin alpha 6
       728358 DEFA1B; defensin alpha 1B
       1991 ELANE; elastase, neutrophil expressed
       3002 GZMB; granzyme B
       4297 KMT2A; lysine methyltransferase 2A
       4299 AFF1; ALF transcription elongation factor 1
       1025 CDK9; cyclin dependent kinase 9
       904 CCNT1; cyclin T1
       905 CCNT2; cyclin T2
       4298 MLLT1; MLLT1 super elongation complex subunit
       4300 MLLT3; MLLT3 super elongation complex subunit
       84444 DOT1L; DOT1 like histone lysine methyltransferase
       4005 LMO2; LIM domain only 2
       5090 PBX3; PBX homeobox 3
       860 RUNX2; RUNX family transcription factor 2
       4086 SMAD1; SMAD family member 1
       51274 KLF3; KLF transcription factor 3
       4208 MEF2C; myocyte enhancer factor 2C
       3205 HOXA9; homeobox A9
       3206 HOXA10; homeobox A10
       221037 JMJD1C; jumonji domain containing 1C
       8091 HMGA2; high mobility group AT-hook 2
       7403 KDM6A; lysine demethylase 6A
       8464 SUPT3H; SPT3 homolog, SAGA and STAGA complex component
       8842 PROM1; prominin 1
       2322 FLT3; fms related receptor tyrosine kinase 3
       55589 BMP2K; BMP2 inducible kinase
       3480 IGF1R; insulin like growth factor 1 receptor
       1027 CDKN1B; cyclin dependent kinase inhibitor 1B
       5218 CDK14; cyclin dependent kinase 14
       4211 MEIS1; Meis homeobox 1
       3207 HOXA11; homeobox A11
       6495 SIX1; SIX homeobox 1
       51804 SIX4; SIX homeobox 4
       2138 EYA1; EYA transcriptional coactivator and phosphatase 1
       1031 CDKN2C; cyclin dependent kinase inhibitor 2C
       3248 HPGD; 15-hydroxyprostaglandin dehydrogenase
       2892 GRIA3; glutamate ionotropic receptor AMPA type subunit 3
       2530 FUT8; fucosyltransferase 8
       30012 TLX3; T cell leukemia homeobox 3
       3195 TLX1; T cell leukemia homeobox 1
       64919 BCL11B; BCL11 transcription factor B
       8861 LDB1; LIM domain binding 1
       4066 LYL1; LYL1 basic helix-loop-helix family member
       3087 HHEX; hematopoietically expressed homeobox
       171558 PTCRA; pre T cell antigen receptor alpha
       5966 REL; REL proto-oncogene, NF-kB subunit
       894 CCND2; cyclin D2
       329 BIRC2; baculoviral IAP repeat containing 2
       330 BIRC3; baculoviral IAP repeat containing 3
       7185 TRAF1; TNF receptor associated factor 1
       598 BCL2L1; BCL2 like 1
       942 CD86; CD86 molecule
       958 CD40; CD40 molecule
       604 BCL6; BCL6 transcription repressor
       102723407 IGH; immunoglobulin heavy variable 4-38-2-like
       4094 MAF; MAF bZIP transcription factor
       3695 ITGB7; integrin subunit beta 7
       7468 NSD2; nuclear receptor binding SET domain protein 2
       440093 H3-5; H3.5 histone
       3021 H3-3B; H3.3 histone B
       8351 H3C4; H3 clustered histone 4
       8352 H3C3; H3 clustered histone 3
       8350 H3C1; H3 clustered histone 1
       3020 H3-3A; H3.3 histone A
       8290 H3-4; H3.4 histone, cluster member
       126961 H3C14; H3 clustered histone 14
       333932 H3C15; H3 clustered histone 15
       653604 H3C13; H3 clustered histone 13
       8353 H3C6; H3 clustered histone 6
       8354 H3C11; H3 clustered histone 11
       8355 H3C8; H3 clustered histone 8
       8356 H3C12; H3 clustered histone 12
       8357 H3C10; H3 clustered histone 10
       8358 H3C2; H3 clustered histone 2
       8968 H3C7; H3 clustered histone 7
       5079 PAX5; paired box 5
       7849 PAX8; paired box 8
       5468 PPARG; peroxisome proliferator activated receptor gamma
       6256 RXRA; retinoid X receptor alpha
       6257 RXRB; retinoid X receptor beta
       6258 RXRG; retinoid X receptor gamma
       5546 PRCC; proline rich mitotic checkpoint control factor
       7030 TFE3; transcription factor binding to IGHM enhancer 3
       1026 CDKN1A; cyclin dependent kinase inhibitor 1A
       7113 TMPRSS2; transmembrane serine protease 2
       2078 ERG; ETS transcription factor ERG
       5328 PLAU; plasminogen activator, urokinase
       5327 PLAT; plasminogen activator, tissue type
       4314 MMP3; matrix metallopeptidase 3
       4318 MMP9; matrix metallopeptidase 9
       6935 ZEB1; zinc finger E-box binding homeobox 1
       7850 IL1R2; interleukin 1 receptor type 2
       6692 SPINT1; serine peptidase inhibitor, Kunitz type 1
       2115 ETV1; ETS variant transcription factor 1
       2118 ETV4; ETS variant transcription factor 4
       2119 ETV5; ETS variant transcription factor 5
       85414 SLC45A3; solute carrier family 45 member 3
       2005 ELK4; ETS transcription factor ELK4
       1655 DDX5; DEAD-box helicase 5
       4613 MYCN; MYCN proto-oncogene, bHLH transcription factor
       4149 MAX; MYC associated factor X
       4193 MDM2; MDM2 proto-oncogene
       5747 PTK2; protein tyrosine kinase 2
       7157 TP53; tumor protein p53
       648 BMI1; BMI1 proto-oncogene, polycomb ring finger
       100532731 COMMD3-BMI1; COMMD3-BMI1 readthrough
       6667 SP1; Sp1 transcription factor
       7709 ZBTB17; zinc finger and BTB domain containing 17
       4914 NTRK1; neurotrophic receptor tyrosine kinase 1
       4804 NGFR; nerve growth factor receptor
       4221 MEN1; menin 1
       2130 EWSR1; EWS RNA binding protein 1
       2313 FLI1; Fli-1 proto-oncogene, ETS transcription factor
       3479 IGF1; insulin like growth factor 1
       3398 ID2; inhibitor of DNA binding 2
       7048 TGFBR2; transforming growth factor beta receptor 2
       3486 IGFBP3; insulin like growth factor binding protein 3
       54738 FEV; FEV transcription factor, ETS family member
       466 ATF1; activating transcription factor 1
       9915 ARNT2; aryl hydrocarbon receptor nuclear translocator 2
       472 ATM; ATM serine/threonine kinase
       4286 MITF; melanocyte inducing transcription factor
       7490 WT1; WT1 transcription factor
       5154 PDGFA; platelet derived growth factor subunit A
       3560 IL2RB; interleukin 2 receptor subunit beta
       8938 BAIAP3; BAI1 associated protein 3
       7102 TSPAN7; tetraspanin 7
       4291 MLF1; myeloid leukemia factor 1
       8013 NR4A3; nuclear receptor subfamily 4 group A member 3
       8148 TAF15; TATA-box binding protein associated factor 15
       2521 FUS; FUS RNA binding protein
       1649 DDIT3; DNA damage inducible transcript 3
       1051 CEBPB; CCAAT enhancer binding protein beta
       3569 IL6; interleukin 6
       64332 NFKBIZ; NFKB inhibitor zeta
       4790 NFKB1; nuclear factor kappa B subunit 1
       5970 RELA; RELA proto-oncogene, NF-kB subunit
       3576 CXCL8; C-X-C motif chemokine ligand 8
       5081 PAX7; paired box 7
       5077 PAX3; paired box 3
       2308 FOXO1; forkhead box O1
       2321 FLT1; fms related receptor tyrosine kinase 1
       26039 SS18L1; SS18L1 subunit of BAF chromatin remodeling complex
       6760 SS18; SS18 subunit of BAF chromatin remodeling complex
       6756 SSX1; SSX family member 1
       6757 SSX2; SSX family member 2
       727837 SSX2B; SSX family member 2B
       26471 NUPR1; nuclear protein 1, transcriptional regulator
       79058 ASPSCR1; ASPSCR1 tether for SLC2A4, UBX domain containing
       4233 MET; MET proto-oncogene, receptor tyrosine kinase
       1647 GADD45A; growth arrest and DNA damage inducible alpha
       4616 GADD45B; growth arrest and DNA damage inducible beta
       10912 GADD45G; growth arrest and DNA damage inducible gamma
       581 BAX; BCL2 associated X, apoptosis regulator
       578 BAK1; BCL2 antagonist/killer 1
       1643 DDB2; damage specific DNA binding protein 2
       51426 POLK; DNA polymerase kappa
K08367 RUNX1; runt-related transcription factor 1
K05090 CSF1R; macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1]
K10789 MPO; myeloperoxidase [EC:1.11.2.2]
K05427 CSF2; granulocyte-macrophage colony-stimulating factor
K04736 IL3; interleukin 3
K10053 RUNX1T1; CBFA2/RNUX1 translocation partner 1
K06067 HDAC1_2; histone deacetylase 1/2 [EC:3.5.1.98]
K06067 HDAC1_2; histone deacetylase 1/2 [EC:3.5.1.98]
K11644 SIN3A; paired amphipathic helix protein Sin3a
K04650 NCOR1; nuclear receptor co-repressor 1
K09055 CEBPA; CCAAT/enhancer binding protein (C/EBP), alpha
K02633 PER2; period circadian protein 2
K09438 SPI1; transcription factor PU.1
K04391 CD14; monocyte differentiation antigen CD14
K06461 ITGAM; integrin alpha M
K06498 FCGR1A; high affinity immunoglobulin gamma Fc receptor I
K10056 JUP; junction plakoglobin
K10054 PML; E3 SUMO-protein ligase PML [EC:2.3.2.-]
K08527 RARA; retinoic acid receptor alpha
K06627 CCNA; cyclin-A
K06627 CCNA; cyclin-A
K10051 CEBPE; CCAAT/enhancer binding protein (C/EBP), epsilon
K02162 BCL2A1; hematopoietic Bcl-2-related protein A1
K10055 ZBTB16; zinc finger and BTB domain-containing protein 16
K04377 MYC; Myc proto-oncogene protein
K21946 DUSP6; dual specificity phosphatase 6 [EC:3.1.3.16 3.1.3.48]
K09063 TCF3; transcription factor E2-alpha
K09355 PBX1; pre-B-cell leukemia transcription factor 1
K01558 WNT16; wingless-type MMTV integration site family, member 16
K03211 ETV6_7; ETS translocation variant 6/7
K03211 ETV6_7; ETS translocation variant 6/7
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K01327 ELANE; leukocyte elastase [EC:3.4.21.37]
K01353 GZMB; granzyme B [EC:3.4.21.79]
K09186 MLL1; [histone H3]-lysine4 N-trimethyltransferase MLL1 [EC:2.1.1.354]
K15184 AFF1; AF4/FMR2 family member 1
K02211 CDK9; cyclin-dependent kinase 9 [EC:2.7.11.22 2.7.11.23]
K15188 CCNT; cyclin T
K15188 CCNT; cyclin T
K15187 MLLT1_3; YEATS domain-containing protein 1/3
K15187 MLLT1_3; YEATS domain-containing protein 1/3
K11427 DOT1L; [histone H3]-lysine79 N-trimethyltransferase [EC:2.1.1.360]
K15612 LMO2; rhombotin-2
K15610 PBX3; pre-B-cell leukemia transcription factor 3
K09278 RUNX2; runt-related transcription factor 2
K04676 SMAD1; mothers against decapentaplegic homolog 1
K15605 KLF3; krueppel-like factor 3
K04454 MEF2C; MADS-box transcription enhancer factor 2C
K21950 HOXA9; homeobox protein Hox-A9
K17443 HOXA10; homrobox protein Hox-A10
K11449 JMJD1C; jumonji domain-containing protein 1C [EC:1.14.11.-]
K09283 HMGA2; high mobility group AT-hook protein 2
K11447 UTX; lysine-specific demethylase 6A [EC:1.14.11.68]
K11313 SUPT3H; transcription initiation protein SPT3
K06532 PROM1; prominin 1
K05092 FLT3; fms-related tyrosine kinase 3 [EC:2.7.10.1]
K08854 BMP2K; BMP2 inducible kinase [EC:2.7.11.1]
K05087 IGF1R; insulin-like growth factor 1 receptor [EC:2.7.10.1]
K06624 CDKN1B; cyclin-dependent kinase inhibitor 1B
K08821 CDK14; cyclin-dependent kinase 14 [EC:2.7.11.22]
K15613 MEIS1; homeobox protein Meis1
K21951 HOXA11; homeobox protein Hox-A11
K15614 SIX1; homeobox protein SIX1
K15615 SIX4; homeobox protein SIX4
K15616 EYA1; eyes absent homolog 1 [EC:3.1.3.48]
K06622 CDKN2C; cyclin-dependent kinase inhibitor 2C
K00069 HPGD; 15-hydroxyprostaglandin dehydrogenase (NAD) [EC:1.1.1.141]
K05199 GRIA3; glutamate receptor 3
K00717 FUT8; glycoprotein 6-alpha-L-fucosyltransferase [EC:2.4.1.68]
K15607 TLX3; T-cell leukemia homeobox protein 3
K09340 TLX1; T-cell leukemia homeobox protein 1
K22046 BCL11B; B-cell lymphoma/leukemia 11B
K15617 LDB1; LIM domain-binding protein 1
K15604 LYL1; protein lyl-1
K08024 HHEX; homeobox protein HEX
K06056 PTCRA; pre T-cell antigen receptor alpha
K09254 REL; c-Rel proto-oncogene protein
K10151 CCND2; G1/S-specific cyclin-D2
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K03172 TRAF1; TNF receptor-associated factor 1
K04570 BCL2L1; Bcl-2-like 1 (apoptosis regulator Bcl-X)
K05413 CD86; CD86 antigen
K03160 TNFRSF5; tumor necrosis factor receptor superfamily member 5
K15618 BCL6; B-cell lymphoma 6 protein
K06856 IGH; immunoglobulin heavy chain
K09035 CMAF; transcription factor Maf
K06590 ITGB7; integrin beta 7
K11424 WHSC1; [histone H3]-lysine36 N-dimethyltransferase NSD2 [EC:2.1.1.357]
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K09383 PAX5; paired box protein 5
K09293 PAX8; paired box protein 8
K08530 NR1C3; peroxisome proliferator-activated receptor gamma
K08524 RXRA; retinoid X receptor alpha
K08525 RXRB; retinoid X receptor beta
K08526 RXRG; retinoid X receptor gamma
K13105 PRCC; proline-rich protein PRCC
K09105 TFE3; transcription factor E3
K06625 CDKN1A; cyclin-dependent kinase inhibitor 1A
K09633 TMPRSS2; transmembrane protease serine 2 [EC:3.4.21.122]
K09435 ERG; transcriptional regulator ERG
K01348 PLAU; urokinase plasminogen activator [EC:3.4.21.73]
K01343 PLAT; tissue plasminogen activator [EC:3.4.21.68]
K01394 MMP3; matrix metalloproteinase-3 (stromelysin 1, progelatinase) [EC:3.4.24.17]
K01403 MMP9; matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]
K09299 ZEB1; zinc finger homeobox protein 1
K04387 IL1R2; interleukin 1 receptor type II
K15619 SPINT1; Kunitz-type protease inhibitor 1
K09431 ETV1; ets translocation variant 1
K15592 ETV4; ets translocation variant 4
K15593 ETV5; ets translocation variant 5
K15379 SLC45A3; solute carrier family 45, member 3
K04376 ELK4; ETS domain-containing protein Elk-4
K12823 DDX5; ATP-dependent RNA helicase DDX5/DBP2 [EC:5.6.2.7]
K09109 NMYC; N-myc proto-oncogene protein
K04453 MAX; Max protein
K06643 MDM2; E3 ubiquitin-protein ligase Mdm2 [EC:2.3.2.27]
K05725 PTK2; focal adhesion kinase 1 [EC:2.7.10.2]
K04451 TP53; tumor protein p53
K11459 PCGF4; polycomb group RING finger protein 4
K11459 PCGF4; polycomb group RING finger protein 4
K04684 SP1; transcription factor Sp1
K10500 ZBTB17; zinc finger and BTB domain-containing protein 17
K03176 NTRK1; neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]
K02583 NGFR; tumor necrosis factor receptor superfamily member 16
K14970 MEN1; menin
K13209 EWSR1; RNA-binding protein EWS
K09436 FLI1; friend leukemia integration 1 transcription factor
K05459 IGF1; insulin-like growth factor 1
K17693 ID2; DNA-binding protein inhibitor ID2
K04388 TGFBR2; TGF-beta receptor type-2 [EC:2.7.11.30]
K10138 IGFBP3; insulin-like growth factor-binding protein 3
K09437 FEV; ETS oncogene family protein FEV
K09053 ATF1; activating transcription factor 1
K15589 ARNT2; aryl hydrocarbon receptor nuclear translocator 2
K04728 ATM; serine-protein kinase ATM [EC:2.7.11.1]
K09455 MITF; microphthalmia-associated transcription factor
K09234 WT1; Wilms tumor protein 1
K04359 PDGFA; platelet-derived growth factor subunit A
K05069 IL2RB; interleukin 2 receptor beta
K15621 BAIAP3; BAI1-associated protein 3
K06571 TSPAN7; tetraspanin-7
K15622 MLF1; myeloid leukemia factor 1
K08559 NR4A3; nuclear receptor subfamily 4 group A member 3
K14651 TAF15; transcription initiation factor TFIID subunit 15
K13098 TLS; RNA-binding protein FUS
K04452 DDIT3; DNA damage-inducible transcript 3
K10048 CEBPB; CCAAT/enhancer binding protein (C/EBP), beta
K05405 IL6; interleukin 6
K14242 NFKBIZ; NF-kappa-B inhibitor zeta
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K10030 IL8; interleukin 8
K09381 PAX3_7; paired box protein 3/7
K09381 PAX3_7; paired box protein 3/7
K07201 FOXO1; forkhead box protein O1
K05096 FLT1; FMS-like tyrosine kinase 1 [EC:2.7.10.1]
K15623 SS18; protein SSXT
K15623 SS18; protein SSXT
K15624 SSX1; protein SSX1
K15625 SSX2; protein SSX2
K15625 SSX2; protein SSX2
K15626 NUPR1; nuclear protein 1
K15627 ASPSCR1; tether containing UBX domain for GLUT4
K05099 MET; proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K02159 BAX; apoptosis regulator BAX
K14021 BAK; Bcl-2 homologous antagonist/killer
K10140 DDB2; DNA damage-binding protein 2
K03511 POLK; DNA polymerase kappa [EC:2.7.7.7]
     05206 MicroRNAs in cancer [PATH:hsa05206]
     05205 Proteoglycans in cancer [PATH:hsa05205]
     05204 Chemical carcinogenesis - DNA adducts [PATH:hsa05204]
     05207 Chemical carcinogenesis - receptor activation [PATH:hsa05207]
     05208 Chemical carcinogenesis - reactive oxygen species [PATH:hsa05208]
     05203 Viral carcinogenesis [PATH:hsa05203]
     05230 Central carbon metabolism in cancer [PATH:hsa05230]
     05231 Choline metabolism in cancer [PATH:hsa05231]
     05235 PD-L1 expression and PD-1 checkpoint pathway in cancer [PATH:hsa05235]
 
   09162 Cancer: specific types
 
   09172 Infectious disease: viral
 
   09171 Infectious disease: bacterial
     05110 Vibrio cholerae infection [PATH:hsa05110]
     05120 Epithelial cell signaling in Helicobacter pylori infection [PATH:hsa05120]
     05130 Pathogenic Escherichia coli infection [PATH:hsa05130]
     05132 Salmonella infection [PATH:hsa05132]
     05131 Shigellosis [PATH:hsa05131]
     05135 Yersinia infection [PATH:hsa05135]
     05133 Pertussis [PATH:hsa05133]
     05134 Legionellosis [PATH:hsa05134]
     05150 Staphylococcus aureus infection [PATH:hsa05150]
       3857 KRT9; keratin 9
       3858 KRT10; keratin 10
       3859 KRT12; keratin 12
       3860 KRT13; keratin 13
       3861 KRT14; keratin 14
       3866 KRT15; keratin 15
       3868 KRT16; keratin 16
       3872 KRT17; keratin 17
       3875 KRT18; keratin 18
       3880 KRT19; keratin 19
       3881 KRT31; keratin 31
       3882 KRT32; keratin 32
       3883 KRT33A; keratin 33A
       3884 KRT33B; keratin 33B
       3885 KRT34; keratin 34
       3886 KRT35; keratin 35
       125115 KRT40; keratin 40
       390792 KRT39; keratin 39
       25984 KRT23; keratin 23
       147183 KRT25; keratin 25
       162605 KRT28; keratin 28
       192666 KRT24; keratin 24
       342574 KRT27; keratin 27
       54474 KRT20; keratin 20
       8687 KRT38; keratin 38
       8688 KRT37; keratin 37
       8689 KRT36; keratin 36
       100653049 keratin, type I cuticular Ha4
       353288 KRT26; keratin 26
       2266 FGG; fibrinogen gamma chain
       718 C3; complement C3
       629 CFB; complement factor B
       1675 CFD; complement factor D
       3075 CFH; complement factor H
       4153 MBL2; mannose binding lectin 2
       5648 MASP1; MBL associated serine protease 1
       10747 MASP2; MBL associated serine protease 2
       102723407 IGH; immunoglobulin heavy variable 4-38-2-like
       712 C1QA; complement C1q A chain
       713 C1QB; complement C1q B chain
       714 C1QC; complement C1q C chain
       715 C1R; complement C1r
       716 C1S; complement C1s
       717 C2; complement C2
       720 C4A; complement C4A (Chido/Rodgers blood group)
       721 C4B; complement C4B (Chido/Rodgers blood group)
       727 C5; complement C5
       719 C3AR1; complement C3a receptor 1
       728 C5AR1; complement C5a receptor 1
       2209 FCGR1A; Fc gamma receptor Ia
       2212 FCGR2A; Fc gamma receptor IIa
       2213 FCGR2B; Fc gamma receptor IIb
       9103 FCGR2C; Fc gamma receptor IIc (gene/pseudogene)
       2214 FCGR3A; Fc gamma receptor IIIa
       2215 FCGR3B; Fc gamma receptor IIIb
       2204 FCAR; Fc alpha receptor
       2359 FPR3; formyl peptide receptor 3
       2358 FPR2; formyl peptide receptor 2
       2357 FPR1; formyl peptide receptor 1
       5340 PLG; plasminogen
       3426 CFI; complement factor I
       6404 SELPLG; selectin P ligand
       6403 SELP; selectin P
       3383 ICAM1; intercellular adhesion molecule 1
       3683 ITGAL; integrin subunit alpha L
       3684 ITGAM; integrin subunit alpha M
       3689 ITGB2; integrin subunit beta 2
       1672 DEFB1; defensin beta 1
       1673 DEFB4A; defensin beta 4A
       100289462 DEFB4B; defensin beta 4B
       414325 DEFB103A; defensin beta 103A
       55894 DEFB103B; defensin beta 103B
       1667 DEFA1; defensin alpha 1
       1668 DEFA3; defensin alpha 3
       1669 DEFA4; defensin alpha 4
       1670 DEFA5; defensin alpha 5
       1671 DEFA6; defensin alpha 6
       728358 DEFA1B; defensin alpha 1B
       820 CAMP; cathelicidin antimicrobial peptide
       1828 DSG1; desmoglein 1
       3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
       3109 HLA-DMB; major histocompatibility complex, class II, DM beta
       3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
       3112 HLA-DOB; major histocompatibility complex, class II, DO beta
       3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
       3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
       3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
       3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
       3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
       3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
       3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
       3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
       3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
       3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
       5724 PTAFR; platelet activating factor receptor
       3586 IL10; interleukin 10
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K03905 FGG; fibrinogen gamma chain
K03990 C3; complement component 3
K01335 CFB; complement factor B [EC:3.4.21.47]
K01334 CFD; complement factor D [EC:3.4.21.46]
K04004 CFH; complement factor H
K03991 MBL; mannose-binding lectin
K03992 MASP1; mannan-binding lectin serine protease 1 [EC:3.4.21.-]
K03993 MASP2; mannan-binding lectin serine protease 2 [EC:3.4.21.104]
K06856 IGH; immunoglobulin heavy chain
K03986 C1QA; complement C1q subcomponent subunit A
K03987 C1QB; complement C1q subcomponent subunit B
K03988 C1QG; complement C1q subcomponent subunit C
K01330 C1R; complement component 1, r subcomponent [EC:3.4.21.41]
K01331 C1S; complement component 1, s subcomponent [EC:3.4.21.42]
K01332 C2; complement component 2 [EC:3.4.21.43]
K03989 C4; complement component 4
K03989 C4; complement component 4
K03994 C5; complement component 5
K04009 C3AR1; C3a anaphylatoxin chemotactic receptor
K04010 C5AR1; C5a anaphylatoxin chemotactic receptor 1
K06498 FCGR1A; high affinity immunoglobulin gamma Fc receptor I
K06472 FCGR2A; low affinity immunoglobulin gamma Fc receptor II-a
K12560 FCGR2B; low affinity immunoglobulin gamma Fc receptor II-b
K16824 FCGR2C; low affinity immunoglobulin gamma Fc receptor II-c
K06463 FCGR3; low affinity immunoglobulin gamma Fc receptor III
K06463 FCGR3; low affinity immunoglobulin gamma Fc receptor III
K06513 FCAR; CD89 antigen
K04173 FPRL; formyl peptide receptor-like
K04173 FPRL; formyl peptide receptor-like
K04172 FPR1; formyl peptide receptor 1
K01315 PLG; plasminogen [EC:3.4.21.7]
K01333 CFI; complement factor I [EC:3.4.21.45]
K06544 SELPLG; selectin P ligand
K06496 SELP; selectin, platelet
K06490 ICAM1; intercellular adhesion molecule 1
K05718 ITGAL; integrin alpha L
K06461 ITGAM; integrin alpha M
K06464 ITGB2; integrin beta 2
K23125 DEFB1; beta-defensin 1
K21100 DEFB4; beta-defensin 4
K21100 DEFB4; beta-defensin 4
K23126 DEFB103; beta-defensin 103
K23126 DEFB103; beta-defensin 103
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K13916 CAMP; cathelicidin antimicrobial peptide
K07596 DSG1; desmoglein 1
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K04279 PTAFR; platelet-activating factor receptor
K05443 IL10; interleukin 10
     05152 Tuberculosis [PATH:hsa05152]
     05100 Bacterial invasion of epithelial cells [PATH:hsa05100]
 
   09174 Infectious disease: parasitic
 
   09163 Immune disease
 
   09164 Neurodegenerative disease
 
   09165 Substance dependence
 
   09166 Cardiovascular disease
 
   09167 Endocrine and metabolic disease
 
   09175 Drug resistance: antimicrobial
 
   09176 Drug resistance: antineoplastic
 
 09180 Brite Hierarchies
 
 09190 Not Included in Pathway or Brite

[ KO | BRITE | KEGG2 | KEGG ]
Last updated: April 25, 2024